• Effect of flow-induced shear stress in nanomaterial uptake by cells: Focus on targeted anti-cancer therapy 

      Shurbaji, Samar; Anlar, Gulsen G.; Hussein, Essraa A.; Elzatahry, Ahmed; Yalcin, Huseyin C. ( MDPI , 2020 , Article)
      © 2020 by the authors. Licensee MDPI, Basel, Switzerland. Recently, nanomedicines have gained a great deal of attention in diverse biomedical applications, including anti-cancer therapy. Being different from normal tissue, ...
    • Metal-based nanoparticles: Promising tools for the management of cardiovascular diseases 

      Nour K., Younis; Ghoubaira, Joseph A.; Bassil, Emmanuel P.; Tantawi, Houda N.; Eid, Ali H. ( Elsevier , 2021 , Article)
      Cardiovascular disease (CVD) is the leading cause of death worldwide. A search for more effective treatments of CVD is increasingly needed. Major advances in nanotechnology opened new avenues in CVD therapeutics. Owing to ...
    • Nano-targeting vascular remodeling in cancer: Recent developments and future directions 

      Roberta, Giordo; Wehbe, Zena; Paliogiannis, Panagiotis; Eid, Ali H.; Mangoni, Arduino A.; ... more authors ( Elsevier , 2022 , Article Review)
      Tumor growth and progression are strictly dependent on the adequate blood supply of oxygen and nutrients. The formation of new blood vessels and vascular networks is essential to ensure this demand. Blood vessels also ...
    • Nanomedicine for Cancer. 

      Younis, Nour K; Yassine, Hadi M; Eid, Ali H ( Bentham Science Publishers , 2022 , Other)
      Over the past decades, oncology has occupied the lion’s share of all nanomedical applications [1-3]. In 2020, up to 65% of the clinical trials involving nanomaterials were attending to cancer therapeutics and diagnostics ...
    • Nanoparticles: Attractive tools to treat colorectal cancer 

      Nour K., Younis; Roumieh, Rami; Bassil, Emmanuel P.; Ghoubaira, Joseph A.; Kobeissy, Firas; ... more authors ( Elsevier , 2022 , Article)
      Colorectal Cancer (CRC) is one of the leading causes of cancer-related deaths worldwide. Despite the notable advances achieved over the last few decades, CRC remains a hard-to-treat deadly disease in many patients. This ...